Physician profile
Gary Shelton
NPI 1396803433
$1,544.33
in general payments reported to CMS, 2019-2025
16 companies · $680 in 2025
The $680 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.30 · 2022: $206 · 2024: $613 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205 · Education: $87.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.99 |
| Education | $87.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fennec Pharmaceuticals, INC. | $277.81 | 2025 | Fyarro |
| Janssen Biotech, INC. | $202.34 | 2024 | Tecvayli, Darzalex |
| Glaxosmithkline, LLC. | $148.81 | 2024 | Jemperli, Zejula |
| Syndax Pharmaceuticals, INC. | $143.87 | 2025 | |
| Exelixis INC. | $135.00 | 2022 | |
| Genmab U.S., INC. | $134.77 | 2025 | Epkinly |
| Astrazeneca Pharmaceuticals LP | $117.81 | 2024 | Enhertu |
| Seagen INC. | $87.99 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.05 | 2022 | |
| Caris Mpi, INC. | $70.70 | 2025 | Mi Cancer Seek |
| Alnylam Pharmaceuticals INC. | $33.48 | 2025 | Amvuttra |
| Emd Serono, INC. | $30.59 | 2024 | |
| Amgen INC. | $30.20 | 2021 | |
| Celgene Corporation | $25.77 | 2024 | Pomalyst |
| Geron Corporation | $19.04 | 2025 | Rytelo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Shelton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.